Clozapine-induced Cardiomyopathy: A Case Report.
| Autor: | Hariri E; Department of Internal Medicine, Cleveland Clinic Cleveland, OH., Scandinaro A; Department of Internal Medicine, Cleveland Clinic Cleveland, OH., Al Hammoud MM; Lebanese American University, Gilbert and Rose-Marie Chagoury School of Medicine Beirut, Lebanon., Kasper A; Department of Pharmacy, Cleveland Clinic Cleveland, OH., Parris C; Ohio State University Wexner Medical Center, Department of Psychiatry Columbus, OH., Bakhtadzi B; Deparment of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Cleveland, OH., Higgins A; Deparment of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Cleveland, OH. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | US cardiology [US Cardiol] 2023 Feb 09; Vol. 17, pp. e01. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023). |
| DOI: | 10.15420/usc.2022.22 |
| Abstrakt: | The diagnosis and treatment of new-onset systolic dysfunction can be challenging, particularly in patients presenting with cardiogenic shock. We present a case of a young African-American man who was admitted for cardiogenic shock following an admission a month earlier for treatment- resistant psychosis. He was diagnosed with medication-induced cardiomyopathy, which resolved with a remarkable recovery of his systolic function after discontinuation of the culprit medication, clozapine. Competing Interests: Disclosure: The authors have no conflicts of interest to declare. Data availability: The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Ethics: This study was performed in line with the principles of the Declaration of Helsinki. Consent: All patients have given written informed consent (Copyright © The Author(s), 2023. Published by Radcliffe Group Ltd.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|